Inhibitor Therapeutics's total assets for Q1 2025 were $4.51M, a decrease of -20.89% from the previous quarter. INTI total liabilities were $3.15M for the fiscal quarter, a -15.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.